$0.070
(0%)
|
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 13 November 2026 at 10:15am | ||||
RHINOMED LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (13-Nov) $11,471,000 (1,037th) |
Close (30-Jun) $0.070 |
Volume (30-Jun) 0 |
Shortsold (8-Jan) 4,400 (0.00%) (473rd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.04 |
Rhinomed Limited Audited Financial Report FY21
RNO released this announcement to the ASX on 28 September 2021, 10:27. The announcement is not marked as price sensitive, and is 55 page(s) in length and 0.99MB in size.
You can view all announcements from RNO and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from RNO | |
|---|---|
| Change in substantial holding WG | 18 May 2023, 9:23 |
| App 3Y MJ | 4 May 2023, 10:56 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 28 April 2023, 9:19 |
| Rhinomed Limited Audited Financial Report FY21 | 28 September 2021, 10:27 |
| Rhinomed appoints Rhinoswab distributors - supplementary dis | 14 September 2021, 11:04 |
| VIC Government orders for Rhinoswab | 10 September 2021, 9:23 |
| World's first paediatric swab | 27 August 2021, 9:36 |
If you were already registered, log in here.
If you were already registered, log in here.